Navigation Links
Suspected Bird Flu Death Creates Panic In Hong Kong

A man who died on Saturday suspected to be of bird flu has created panic in Hong Kong, which was put on high alert.//

The 32-year-old man is believed to have contracted the virus while visiting markets in Guangzhou, a busy city in China's Guangdong province, bordering Hong Kong.

He developed fever and pneumonia on Feb 22 and died within nine days of hospitalisation.

Many people travel between Hong Kong and Guangzhou, heightening the risk of persons with the virus entering Hong Kong. Much of Hong Kong's chicken supply also comes from farms in this area.

The Centre for Health Protection (CHP) held an emergency meeting Friday, after being notified of the suspected case from the health officials in China.

The news prompted calls from lawmakers to tighten up border health checks on travellers and on poultry imports.

Hong Kong has had no human cases of bird flu in the current outbreak, but CHP director Leung Pak-yin warned that the threat was increasing.

"We expect there could be human cases in Hong Kong and we all need to be well prepared for that," he said.

Hong Kong witnessed the first-ever human cases of bird flu in 1997 when 18 people were infected, of whom six died. The outbreak was the first known instance of the virus jumping the species barrier.

Since then the territory has set up strict regulations on the farming and selling of chickens. These include vaccinating poultry at farms and regular clean-up days at markets.

In recent weeks, a number of wild birds have been found dead with the H5N1 virus heightening fears that Hong Kong will soon record its first human victim.

--Edited IANS
'"/>




Page: 1

Related medicine news :

1. Mother And Daughter Suspected to Be Witches, Killed
2. Holy Cow! Rare “Mad Sheep” Strain Suspected in Frane
3. First Suspected Bird Flu Case In Serbia: Samples Sent For Analysis
4. Vet Dies Of Suspected Bird Flu, Samples Sent To NIV
5. Clostridium Infection Suspected In Abortion Deaths
6. WHO Officials Investigating Eight Suspected Bird Flu Cases
7. 31 Year Old Man Critical And Is Suspected To Have Contracted Bird Flu Virus In Shenzhen
8. A New Test Developed to Identify Suspected Bowel Cancer Patients
9. Suspected Dengue Case Reported in Kalyan Area of Thane
10. Seven Dead in Maharashtra Due to Suspected Chikungunya
11. Bird Flu in Thailand Suspected to be H5N1 Strain
Post Your Comments:
(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2
... and should get a control over the HIV epidemic by... //warned Ashok Alexander, the director of the Bil...ations official. According to Ashok Alexander who ...dian HIV-prevention project, "The signs are still ...
...es not increase the chances of heart attack, but c...movie mythology. //The study reported that ‘while ...ack, use of cocaine could lift the likelihood 20-f...ey and Harvard academics is the first to analyse t...
...ted on Monday that millions of newborn babies, //c...reventable diseases in spite of promises of better...he WHO reported that because of AIDS and armed con... countries has not improved in recent years and in...
...isk of dementia according to recent research. // P...ower risk of dementia and Alzheimer’s disease. DHA... is a key factor that is required for the proper f...us system. These findings have been published in t...
Other Medicine News:Health News:India warned of Impending AIDS Disaster 2Health News:WHO Attributes Death of Millions in Africa to Treatable diseases 2
(Date:9/4/2008)... Patient Identification for Targeted Therapies ...atment HUNTINGTON BEACH, Calif., and AMSTERDAM,...orld leader in molecular cancer diagnostics,today...gnostic test that,allows physicians to quantitativ...trogen receptor (ER), progesterone receptor (PR) a...
(Date:9/3/2008)...pt. 3 /- Simcere,Pharmaceut...nd supplier of,branded generic pharmaceuticals and...product Endu (also known as Endostar) in China,an...cal study., At the request of the SFDA, Simcere i...date the safety and therapeutic efficacy of Endu, ...
(Date:9/3/2008)...and GENEVA, Sept. 3 /- Artelis SA and... based monoclonal antibody,production with the ach...per liter. This record level was accomplished by a...high-performance stable Selexis CHO,production cel...tists at,Selexis SA using their proprietary Selexi...
(Date:9/3/2008)...erations, Updates Zingo Launch Progress and Adlea ... Conference Call Today at 11:30 am ET,...-FirstCall/ -- Anesiva,Inc. (Nasdaq: ANSV ) anno...ations to focus on commercial and late-stage produ...pecialty pharmaceutical pain management,company. T...
Breaking Medicine Technology:Agendia Launches TargetPrint(R) for Breast Cancer Patients 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 2Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 2Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 4Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 5Amylin Pharmaceuticals Initiates Phase 2B Dose Ranging Clinical Study of Pramlintide Metreleptin Combination Treatment in Obesity 1975 1Amylin Pharmaceuticals Initiates Phase 2B Dose Ranging Clinical Study of Pramlintide Metreleptin Combination Treatment in Obesity 1975 2Amylin Pharmaceuticals Initiates Phase 2B Dose Ranging Clinical Study of Pramlintide Metreleptin Combination Treatment in Obesity 1975 3Amylin Pharmaceuticals Initiates Phase 2B Dose Ranging Clinical Study of Pramlintide Metreleptin Combination Treatment in Obesity 1975 4Amylin Pharmaceuticals Initiates Phase 2B Dose Ranging Clinical Study of Pramlintide Metreleptin Combination Treatment in Obesity 1975 5eResearchTechnology Reports First Quarter 2008 Results 5107 1eResearchTechnology Reports First Quarter 2008 Results 5107 2eResearchTechnology Reports First Quarter 2008 Results 5107 3eResearchTechnology Reports First Quarter 2008 Results 5107 4eResearchTechnology Reports First Quarter 2008 Results 5107 5eResearchTechnology Reports First Quarter 2008 Results 5107 6eResearchTechnology Reports First Quarter 2008 Results 5107 7eResearchTechnology Reports First Quarter 2008 Results 5107 8eResearchTechnology Reports First Quarter 2008 Results 5107 9Verenium Reports Financial Results for the First Quarter 2008 5104 1Verenium Reports Financial Results for the First Quarter 2008 5104 2Verenium Reports Financial Results for the First Quarter 2008 5104 3Verenium Reports Financial Results for the First Quarter 2008 5104 4Verenium Reports Financial Results for the First Quarter 2008 5104 5Verenium Reports Financial Results for the First Quarter 2008 5104 6Verenium Reports Financial Results for the First Quarter 2008 5104 7Verenium Reports Financial Results for the First Quarter 2008 5104 8Verenium Reports Financial Results for the First Quarter 2008 5104 9Verenium Reports Financial Results for the First Quarter 2008 5104 10Verenium Reports Financial Results for the First Quarter 2008 5104 11Divigel 28R 29 28estradiol gel 29 0 1 Percent Offers Lowest Approved Dose of Estradiol for Treatment of Moderate to Severe Hot Flashes Associated wit 1974 1Divigel 28R 29 28estradiol gel 29 0 1 Percent Offers Lowest Approved Dose of Estradiol for Treatment of Moderate to Severe Hot Flashes Associated wit 1974 2Divigel 28R 29 28estradiol gel 29 0 1 Percent Offers Lowest Approved Dose of Estradiol for Treatment of Moderate to Severe Hot Flashes Associated wit 1974 3
... no new stent thrombosis after two years in,high-r...NA, Spain, May 22, 2007,/PRNewswire-FirstCall/ -- ...-year follow-up data from its TAXUS VI clinical,tr...icacy benefits,associated with a moderate-release ...-eluting stent system -- which is not,approved for...
...up analysis shows no stent thrombosis or MACE,afte...y 22, 2007,/PRNewswire-FirstCall/ -- Boston Scient...itional data from the SPIRIT FIRST, II,and III Cli...y data,for the market-leading TAXUS(R) Express2(TM...NCE(TM) V (PROMUS(TM)) Everolimus,Eluting Coronary...
Other Medicine Technology:Taxus VI Clinical Trial Demonstrates Positive Long-Term Outcomes,for Moderate-Release Paclitaxel-Eluting Stent at Four Years 2Taxus VI Clinical Trial Demonstrates Positive Long-Term Outcomes,for Moderate-Release Paclitaxel-Eluting Stent at Four Years 3SPIRIT Clinical Data Reaffirm Strength of Taxus and Promus,Drug-Eluting Coronary Stent Systems 2SPIRIT Clinical Data Reaffirm Strength of Taxus and Promus,Drug-Eluting Coronary Stent Systems 3
Inquire
Adjustable speed vortex with inter-changeable heads, 110 V
Use the Mo Bio Vortex adapter to process multiple samples at the same time. The adapter holds tubes horizontally to increase cell lysis and mixing efficiency. Ideal for bead beating procedures.
...e Mo Bio Vortex Adapter in conjunction with the Vo...sing the Mo Bio Vortex Adapter is an inexpensive a...hines which offer the same technology. This parti...one time and will fit any Vortex Genie 2 with a 3 ...
Medicine Products: